ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
34.49
-0.43%
US Tech 100
19,430.40
0.14%
S&P 500
5,487.03
0.25%
US Dollar vs CAD
1.37066
-0.08%
Bitcoin
65,030.00
-0.17%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Kite Pharma, Inc. (KITE)

  7. Kite Pharma, Inc. (KITE) News

KITE

KITE PHARMA, INC. (KITE)

Kite Pharma, Inc.
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:KITE
DateTimeSourceHeadlineSymbolCompany
10/13/20174:05PMEdgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(b) (15-12b)NASDAQ:KITEKite Pharma, Inc.
10/05/20172:44PMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:KITEKite Pharma, Inc.
10/03/20174:12PMEdgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:KITEKite Pharma, Inc.
10/03/20174:07PMEdgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:KITEKite Pharma, Inc.
10/03/20174:02PMEdgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:KITEKite Pharma, Inc.
10/03/20173:57PMEdgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:KITEKite Pharma, Inc.
10/03/20173:56PMEdgar (US Regulatory)Post-effective Amendment to an Automatic Shelf Registration of Form S-3asr or Form F-3asr (posasr)NASDAQ:KITEKite Pharma, Inc.
10/03/20173:44PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:KITEKite Pharma, Inc.
10/03/20178:03AMEdgar (US Regulatory)(25-NSE)NASDAQ:KITEKite Pharma, Inc.
10/03/20177:46AMEdgar (US Regulatory)Amended Statement of Ownership: Solicitation (sc 14d9/a)NASDAQ:KITEKite Pharma, Inc.
10/03/20177:45AMBusiness WireGilead Sciences Completes Acquisition of Kite Pharma, Inc.NASDAQ:KITEKite Pharma, Inc.
10/03/20177:17AMEdgar (US Regulatory)Amended Tender Offer Statement by Third Party (sc To-t/a)NASDAQ:KITEKite Pharma, Inc.
10/03/20177:00AMBusiness WireGilead Sciences Completes Tender Offer for All Outstanding Shares of Kite Pharma, Inc.NASDAQ:KITEKite Pharma, Inc.
09/26/20177:54AMEdgar (US Regulatory)Amended Statement of Ownership: Solicitation (sc 14d9/a)NASDAQ:KITEKite Pharma, Inc.
09/26/20177:40AMEdgar (US Regulatory)Amended Tender Offer Statement by Third Party (sc To-t/a)NASDAQ:KITEKite Pharma, Inc.
09/26/20177:30AMBusiness WireGilead Sciences and Kite Pharma Announce Expiration of Hart-Scott-Rodino Waiting PeriodNASDAQ:KITEKite Pharma, Inc.
09/25/20174:17PMEdgar (US Regulatory)Amended Statement of Ownership: Solicitation (sc 14d9/a)NASDAQ:KITEKite Pharma, Inc.
09/25/20174:13PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:KITEKite Pharma, Inc.
09/25/20173:31PMEdgar (US Regulatory)Amended Tender Offer Statement by Third Party (sc To-t/a)NASDAQ:KITEKite Pharma, Inc.
09/22/20173:18PMEdgar (US Regulatory)Amended Tender Offer Statement by Third Party (sc To-t/a)NASDAQ:KITEKite Pharma, Inc.
09/18/20174:29PMEdgar (US Regulatory)Amended Tender Offer Statement by Third Party (sc To-t/a)NASDAQ:KITEKite Pharma, Inc.
09/15/20173:52PMEdgar (US Regulatory)Amended Statement of Ownership: Solicitation (sc 14d9/a)NASDAQ:KITEKite Pharma, Inc.
09/08/20174:30PMEdgar (US Regulatory)Amended Tender Offer Statement by Third Party (sc To-t/a)NASDAQ:KITEKite Pharma, Inc.
09/08/20174:24PMEdgar (US Regulatory)Amended Statement of Ownership: Solicitation (sc 14d9/a)NASDAQ:KITEKite Pharma, Inc.
09/08/201712:37PMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:KITEKite Pharma, Inc.
09/07/20173:12PMEdgar (US Regulatory)Amended Statement of Ownership: Solicitation (sc 14d9/a)NASDAQ:KITEKite Pharma, Inc.
09/05/20173:13PMEdgar (US Regulatory)Statement of Ownership: Solicitation (sc 14d9)NASDAQ:KITEKite Pharma, Inc.
09/05/20173:09PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:KITEKite Pharma, Inc.
09/05/201711:24AMEdgar (US Regulatory)Tender Offer Statement by Third Party (sc To-t)NASDAQ:KITEKite Pharma, Inc.
09/01/20174:28PMEdgar (US Regulatory)Written Communication by the Subject Company Relating to a Third Party Tender Offer (sc14d9c)NASDAQ:KITEKite Pharma, Inc.
 Showing the most relevant articles for your search:NASDAQ:KITE

Your Recent History

USOTC
SFRX
Seafarer Exploration (PK)
USOTC
TSOI
Therapeutic Solutions (PK)
USOTC
CYDY
CytoDyn (QB)
NASDAQ
NB
NioCorp Developments
USOTC
SFLM
SFLMaven (PK)
NASDAQ
DJT
Trump Media and Technology
USOTC
BLLB
Bell Buckle (PK)
USOTC
FNMA
Fannie Mae (QB)
NASDAQ
COOP
Mr Cooper
NASDAQ
AMRN
Amarin
NASDAQ
AVXL
Anavex Life Sciences
NASDAQ
NVDA
NVIDIA
USOTC
MWWC
Marketing Worldwide (PK)
USOTC
KBLB
Kraig Biocraft Laborator... (QB)
USOTC
IQST
iQSTEL (QX)
COIN
SHIBUSD
SHIBA INU
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved